title: Hypoxia, androgen deprivation and systemic metastases in prostate cancer (in response to "Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: an in vivo human study using susceptibility and relaxitivity dynamic MRI": in regard to Alonzi R et al. (Int J Radiat Oncol Biol Phys 2011;80(3):721-727).
authors.forename: Alan
authors.initials: A
authors.lastname: Dal Pra
authors.forename: Michael
authors.initials: M
authors.lastname: Milosevic
authors.forename: Richard
authors.initials: R
authors.lastname: Hill
authors.forename: Bradley
authors.initials: B
authors.lastname: Wouters
authors.forename: Padraig
authors.initials: P
authors.lastname: Warde
authors.forename: Robert G
authors.initials: RG
authors.lastname: Bristow
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D011471:Prostatic Neoplasms / Q000098:blood supply* / Q000188:drug therapy*
chemical_list: D000726:Androgen Antagonists